BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9949235)

  • 1. [Long-term follow-up of combined therapy with large-dose zinc sulfate and low-dose penicillamine in children with hepatolenticular degeneration].
    Li T; Lin R; Du S; Qu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Feb; 16(1):19-21. PubMed ID: 9949235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
    Sinha S; Taly AB
    J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of Wilson's disease: results of a single center experience.
    Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
    J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in zinc metabolism during long-term D-penicillamine treatment of patients with Wilson-Konovalov disease].
    Mzhel'skaia TI; Gomovtseva EV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):356-9. PubMed ID: 6720176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of the treatment of Wilson's disease with zinc sulfate and d-penicillamine].
    Szleper M; Rodo M; Piłkowska E; Członkowska A
    Pol Tyg Lek; 1992 May 18-25; 47(20-21):456-8. PubMed ID: 1437767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.
    Lowette KF; Desmet K; Witters P; Laleman W; Verslype C; Nevens F; Fevery J; Cassiman DM
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):564-71. PubMed ID: 20042865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Follow-up study on the therapeutic efficacy in 80 children with Wilson disease].
    Xie XW; Li T
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 May; 12(5):398-400. PubMed ID: 20497654
    [No Abstract]   [Full Text] [Related]  

  • 8. [The role of zinc in the initial treatment of Wilson's disease in children].
    Cacić M; Percl M; Jadresin O; Kolacek S
    Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
    Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
    Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical curative effects of dimercaptosuccinic acid on hepatolenticular degeneration and the impact of DMSA on biliary trace elements.
    Ren M; Yang R
    Chin Med J (Engl); 1997 Sep; 110(9):694-7. PubMed ID: 9642327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years.
    Brewer GJ; Dick RD; Johnson VD; Fink JK; Kluin KJ; Daniels S
    J Lab Clin Med; 2001 Mar; 137(3):191-8. PubMed ID: 11241029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of Wilson's disease with penicillamine and zinc salts: a follow-up study].
    Li M; Zhang YH; Qin J
    Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):119-22. PubMed ID: 14759316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of Wilson disease].
    Smolarek C; Stremmel W
    Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Wilson's disease with zinc. 5 cases].
    Bona I; Broussolle E; Neuschwander P; Confavreux C; Fontanges T; Accominotti M; Chazot G
    Rev Neurol (Paris); 1993; 149(6-7):393-7. PubMed ID: 8303158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
    J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful long term oral zinc in florid Wilson's disease: a case report.
    Kaur U; Bambery P; Bhushnurmath SR; Deodhar SD; Dilawari JB
    Trop Geogr Med; 1988 Apr; 40(2):161-5. PubMed ID: 3407008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose zinc therapy for maintenance treatment of Wilson's disease.
    Mayet IY
    Clin Pharm; 1990 Dec; 9(12):951-3. PubMed ID: 2292179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.